DGP IgG

Celiac disease is easy to miss. Many people carry it for years with vague symptoms, or none at all, while gluten quietly damages the lining of the small intestine.

This blood test looks for one specific antibody your immune system makes when gluten triggers a celiac reaction. Its real value shows up in the situations where the usual celiac test can read falsely clear.

What This Antibody Signals

DGP IgG (deamidated gliadin peptide immunoglobulin G antibodies) is an antibody your immune system produces against altered fragments of gluten. In the gut, an enzyme called tissue transglutaminase chemically modifies gluten fragments so they stand out more to the immune system, and in celiac disease the immune system responds by making these antibodies. A raised level signals an active, gluten-driven immune response rather than a random finding.

The antibodies come from immune cells that have already learned to react to gluten. In a prospective cohort of at-risk children, a rise in this antibody often appeared before the classic tTG-IgA antibody turned positive, which is part of why it earns a place in certain workups even though it is not the first test most people should reach for.

Celiac Disease Detection

Almost the entire clinical use of this test is celiac disease. Across studies it performs well as an assay, but usually a step behind the standard first-line test, IgA antibodies against tissue transglutaminase (tTG-IgA). The table below shows how it stacks up in different groups.

Source: Catassi et al. 2021 (children under 2); Niveloni et al. 2007 (adults with high suspicion); Dahle et al. 2010 (adults negative on standard serology). The children-under-2 figures are pooled estimates; in the largest single studies tTG-IgA has matched or outperformed this antibody.

What this means for you: as a standalone screen in a typical adult, this antibody is not better than the standard tTG-IgA test. Its edge is in catching the minority of real cases that slip past standard serology, and its strongest signal comes when it and tTG-IgA are positive together. When both are strongly positive, the odds of true celiac disease climb sharply.

Where It Beats the Standard Test

The clearest reason to add this test is low IgA. The standard celiac blood test measures an IgA-class antibody, so if your body makes very little IgA in the first place, that test can read falsely clear even when you have celiac disease. Because this test measures an IgG-class antibody (a different antibody type that is unaffected by IgA deficiency), it still works. In people with selective IgA deficiency, this antibody was positive in most confirmed celiac cases (around 88 percent in one study), which is why guidelines recommend an IgG-based test when IgA is low, though its added role when IgG tissue transglutaminase is already negative is still uncertain.

It also adds value in adults with strong symptoms whose standard antibody tests came back negative. In one adult study, roughly 12 of every 100 biopsy-confirmed celiac patients were identified only by deamidated gliadin peptide testing, without being IgA deficient. Its role in the very young has narrowed: while this antibody can appear early in at-risk children, the 2023 American College of Gastroenterology guidelines reviewed seven studies and found tTG-IgA performed as well or better in children under 2, so routinely adding this test in IgA-sufficient young children is no longer recommended.

Why a Positive Result Is Not a Diagnosis

A high number here can feel alarming, but on its own it is often misleading, and this is not a simple good-number, bad-number marker. In people with normal IgA whose tTG-IgA is normal, a positive result on this test alone rarely means celiac disease. In one pediatric series, only 1 of 40 children with an isolated positive result on this test and a normal tTG-IgA turned out to have biopsy-confirmed celiac disease, a positive predictive value of just 2.5 percent, and even that one child was IgA deficient. The way to reconcile this is to treat the test as an adjunct, not a verdict: it gains meaning only alongside tTG-IgA, your total IgA level, your symptoms, and, when needed, a biopsy.

Tracking Your Response to a Gluten-Free Diet

A single reading is a snapshot. This antibody is most useful watched over time, because it reflects how much your immune system is still reacting to gluten. After starting a strict gluten-free diet, levels fall as the trigger is removed. In adults with biopsy-confirmed celiac disease, both the amount and the share of positive results dropped significantly by 6 months and fell further by 1 year. In children, concentrations decreased roughly 14-fold within months, though many were still above normal at 3 months.

Persistent positivity is meaningful in the other direction: in treated celiac patients, staying positive on deamidated gliadin peptide tests was among the strongest signals of ongoing intestinal damage and imperfect dietary control. A practical rhythm is to get a baseline while you are still eating gluten and being worked up, then, if you are diagnosed and going gluten-free, retest at 6 months and 1 year, and at least annually after that. A trend line tells you far more than any one value about whether your diet is calming the reaction. Even so, antibody levels alone cannot confirm strict adherence: monitoring guidelines stress that a negative result does not prove the diet is perfect, which is why serology is paired with dietitian review and, when needed, biopsy.

When Results Can Be Misleading

The biggest trap is testing after you have already cut out gluten. Because these antibodies fade when the trigger is gone, a gluten-free or low-gluten diet can push your result down toward normal and produce a false negative. For an accurate read, you need to be eating gluten regularly in the weeks before the draw.

• Gluten avoidance before testing: if you have already gone gluten-free, the antibody may have dropped and the test can miss real disease. Test while still eating gluten, then discuss timing with a clinician.
• Assay and cutoff differences: different lab platforms and different threshold definitions can shift whether the same sample reads positive or negative, so results are not perfectly interchangeable between labs.
• Your IgA status: the meaning of a result changes depending on whether your total IgA is normal or low, which is why total IgA is usually checked alongside celiac serology.
• Very young age with normal IgA: in some young, IgA-sufficient children this antibody is less specific, so a positive result carries more false alarms and needs careful interpretation.

What to Do With an Unexpected Result

If this antibody comes back high, the next move is not to panic or to quit gluten immediately, because going gluten-free before a diagnosis can erase the evidence a workup depends on. Instead, make sure the full celiac panel is on the table: tTG-IgA and total serum IgA. If both this antibody and tTG-IgA are positive, especially strongly positive, the case for celiac disease is much stronger and warrants a gastroenterology referral, typically with an intestinal biopsy while you are still eating gluten.

If this test is positive in isolation, with a normal tTG-IgA, the first thing to confirm is your total IgA, since an isolated positive here is most informative when IgA is low. In an IgA-sufficient person, an isolated positive is often a false alarm, and a clinician may reasonably repeat testing or add genetic typing for HLA-DQ2 and DQ8, which can help rule celiac disease out. The through line is that this number is a prompt to complete the picture, not a diagnosis by itself.